Skip to main content
. Author manuscript; available in PMC: 2008 Mar 1.
Published in final edited form as: Virus Res. 2006 Dec 8;124(1-2):212–219. doi: 10.1016/j.virusres.2006.11.006

Figure 4.

Figure 4

Plaque reduction following treatment of HSV-2 infected WB cells with varying doses of H7. A significant decrease in plaque forming unit (pfu) ability occurred at 10 μM H7 and increased to complete reduction at 40 μM (A). H7 (40 μM) continued to completely prevent pfu formation when added up to 12 hours post infection (B). Cytotoxic effects became evident only at doses greater than 60 μM (C).